12 results
8-K
EX-99.2
GOSS
Gossamer Bio Inc
13 Oct 20
Gossamer Bio Announces Topline Results for Phase 2 Trials of Oral GB001 in Asthma and Chronic Rhinosinusitis
7:40am
-to-severe eosinophilic asthma A small minority are treated with approved biologic agents An additional ~1.5 million patients without elevated eosinophils
10-K
rqyjitr5tr5ko 9ss6m
22 Mar 19
Annual report
4:45pm
424B4
ep1u3qa bgir7g
8 Feb 19
Prospectus supplement with pricing info
4:40pm
S-1/A
jb18k
23 Jan 19
IPO registration (amended)
4:39pm
S-1
kmlgkml19qpnv36e48v
21 Dec 18
IPO registration
4:39pm
DRS/A
uy0uv6fh
29 Nov 18
Draft registration statement (amended)
12:00am
DRS
owj0qxznx783ax5a
11 Oct 18
Draft registration statement
12:00am
- Prev
- 1
- Next